APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loxoprofen API (Sodium Salt)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Loxoprofen API (Sodium Salt) Market Outlook and Growth Opportunities 2026

26 December 2025190 pages

Choose your research edition.

Industry ResearchLoxoprofen API (Sodium Salt) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Loxoprofen API (Sodium Salt) Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Loxoprofen API (Sodium Salt) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loxoprofen API (Sodium Salt) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Loxoprofen API (Sodium Salt) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Loxoprofen API (Sodium Salt) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loxoprofen API (Sodium Salt) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Loxoprofen API (Sodium Salt) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Loxoprofen API (Sodium Salt) market include Anlon Healthcare, Daiichi Sankyo, Metrochem, Shinpoong Pharm, Dongyue Pharma, Hunan Jiudian Hongyang, Luoxin Pharmaceutical, Apeloa Pharmaceutical and Zhejiang Starry Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Loxoprofen API (Sodium Salt) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Loxoprofen API (Sodium Salt) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Loxoprofen API (Sodium Salt) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loxoprofen API (Sodium Salt) market size, projected growth trends, production technologies, key applications, and end-use industries.

Loxoprofen API (Sodium Salt) Segment by Company

Anlon Healthcare

Daiichi Sankyo

Metrochem

Shinpoong Pharm

Dongyue Pharma

Hunan Jiudian Hongyang

Luoxin Pharmaceutical

Apeloa Pharmaceutical

Zhejiang Starry Pharmaceutical

Loxoprofen API (Sodium Salt) Segment by Type

Purity ≥99%

Purity<99%

Loxoprofen API (Sodium Salt) Segment by Application

Oral Dosage

External Preparation

Loxoprofen API (Sodium Salt) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Loxoprofen API (Sodium Salt) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Loxoprofen API (Sodium Salt) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Loxoprofen API (Sodium Salt) significant trends, drivers, influence factors in global and regions.

6. To analyze Loxoprofen API (Sodium Salt) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loxoprofen API (Sodium Salt) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loxoprofen API (Sodium Salt) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loxoprofen API (Sodium Salt).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Loxoprofen API (Sodium Salt) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Loxoprofen API (Sodium Salt) industry.

Chapter 3: Detailed analysis of Loxoprofen API (Sodium Salt) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Loxoprofen API (Sodium Salt) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Loxoprofen API (Sodium Salt) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Loxoprofen API (Sodium Salt) Industry Trends Table 2. Loxoprofen API (Sodium Salt) Industry Drivers Table 3. Loxoprofen API (Sodium Salt) Industry Opportunities and Challenges Table 4. Loxoprofen API (Sodium Salt) Industry Restraints Table 5. Global Loxoprofen API (Sodium Salt) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Loxoprofen API (Sodium Salt) Revenue Share by Company (2021-2026) Table 7. Global Loxoprofen API (Sodium Salt) Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Company (2021-2026) Table 9. Global Loxoprofen API (Sodium Salt) Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Loxoprofen API (Sodium Salt) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Loxoprofen API (Sodium Salt) Key Company Manufacturing Base & Headquarters Table 12. Global Loxoprofen API (Sodium Salt) Company, Product Type & Application Table 13. Global Loxoprofen API (Sodium Salt) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Loxoprofen API (Sodium Salt) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity ≥99% Table 18. Significant Companies of Purity<99% Table 19. Global Loxoprofen API (Sodium Salt) Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Loxoprofen API (Sodium Salt) Sales Volume by Type (2021-2026) & (Tons) Table 21. Global Loxoprofen API (Sodium Salt) Sales Volume by Type (2027-2032) & (Tons) Table 22. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Type (2021-2026) Table 23. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Type (2027-2032) Table 24. Global Loxoprofen API (Sodium Salt) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Loxoprofen API (Sodium Salt) Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Loxoprofen API (Sodium Salt) Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Loxoprofen API (Sodium Salt) Sales Value Share by Type (2021-2026) Table 28. Global Loxoprofen API (Sodium Salt) Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oral Dosage Table 30. Significant Companies of External Preparation Table 31. Global Loxoprofen API (Sodium Salt) Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 32. Global Loxoprofen API (Sodium Salt) Sales Volume by Application (2021-2026) & (Tons) Table 33. Global Loxoprofen API (Sodium Salt) Sales Volume by Application (2027-2032) & (Tons) Table 34. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Application (2021-2026) Table 35. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Application (2027-2032) Table 36. Global Loxoprofen API (Sodium Salt) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Loxoprofen API (Sodium Salt) Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Loxoprofen API (Sodium Salt) Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Loxoprofen API (Sodium Salt) Sales Value Share by Application (2021-2026) Table 40. Global Loxoprofen API (Sodium Salt) Sales Value Share by Application (2027-2032) Table 41. Global Loxoprofen API (Sodium Salt) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 42. Global Loxoprofen API (Sodium Salt) Sales by Region (2021-2026) & (Tons) Table 43. Global Loxoprofen API (Sodium Salt) Sales Market Share by Region (2021-2026) Table 44. Global Loxoprofen API (Sodium Salt) Sales by Region (2027-2032) & (Tons) Table 45. Global Loxoprofen API (Sodium Salt) Sales Market Share by Region (2027-2032) Table 46. Global Loxoprofen API (Sodium Salt) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Loxoprofen API (Sodium Salt) Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Loxoprofen API (Sodium Salt) Sales Value Share by Region (2021-2026) Table 49. Global Loxoprofen API (Sodium Salt) Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Loxoprofen API (Sodium Salt) Sales Value Share by Region (2027-2032) Table 51. Global Loxoprofen API (Sodium Salt) Market Average Price (US$/Kg) by Region (2021-2026) Table 52. Global Loxoprofen API (Sodium Salt) Market Average Price (US$/Kg) by Region (2027-2032) Table 53. Global Loxoprofen API (Sodium Salt) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 54. Global Loxoprofen API (Sodium Salt) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Loxoprofen API (Sodium Salt) Sales by Country (2021-2026) & (Tons) Table 56. Global Loxoprofen API (Sodium Salt) Sales Market Share by Country (2021-2026) Table 57. Global Loxoprofen API (Sodium Salt) Sales by Country (2027-2032) & (Tons) Table 58. Global Loxoprofen API (Sodium Salt) Sales Market Share by Country (2027-2032) Table 59. Global Loxoprofen API (Sodium Salt) Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Loxoprofen API (Sodium Salt) Sales Value Market Share by Country (2021-2026) Table 61. Global Loxoprofen API (Sodium Salt) Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Loxoprofen API (Sodium Salt) Sales Value Market Share by Country (2027-2032) Table 63. Anlon Healthcare Company Information Table 64. Anlon Healthcare Business Overview Table 65. Anlon Healthcare Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio Table 67. Anlon Healthcare Recent Development Table 68. Daiichi Sankyo Company Information Table 69. Daiichi Sankyo Business Overview Table 70. Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio Table 72. Daiichi Sankyo Recent Development Table 73. Metrochem Company Information Table 74. Metrochem Business Overview Table 75. Metrochem Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Metrochem Loxoprofen API (Sodium Salt) Product Portfolio Table 77. Metrochem Recent Development Table 78. Shinpoong Pharm Company Information Table 79. Shinpoong Pharm Business Overview Table 80. Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio Table 82. Shinpoong Pharm Recent Development Table 83. Dongyue Pharma Company Information Table 84. Dongyue Pharma Business Overview Table 85. Dongyue Pharma Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio Table 87. Dongyue Pharma Recent Development Table 88. Hunan Jiudian Hongyang Company Information Table 89. Hunan Jiudian Hongyang Business Overview Table 90. Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio Table 92. Hunan Jiudian Hongyang Recent Development Table 93. Luoxin Pharmaceutical Company Information Table 94. Luoxin Pharmaceutical Business Overview Table 95. Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio Table 97. Luoxin Pharmaceutical Recent Development Table 98. Apeloa Pharmaceutical Company Information Table 99. Apeloa Pharmaceutical Business Overview Table 100. Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio Table 102. Apeloa Pharmaceutical Recent Development Table 103. Zhejiang Starry Pharmaceutical Company Information Table 104. Zhejiang Starry Pharmaceutical Business Overview Table 105. Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales (Tons), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio Table 107. Zhejiang Starry Pharmaceutical Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Loxoprofen API (Sodium Salt) Distributors List Table 111. Loxoprofen API (Sodium Salt) Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Loxoprofen API (Sodium Salt) Product Image Figure 2. Global Loxoprofen API (Sodium Salt) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Loxoprofen API (Sodium Salt) Sales (2021-2032) & (Tons) Figure 5. Global Loxoprofen API (Sodium Salt) Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Loxoprofen API (Sodium Salt) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity ≥99% Image Figure 10. Purity<99% Image Figure 11. Global Loxoprofen API (Sodium Salt) Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Loxoprofen API (Sodium Salt) Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Type (2021-2032) Figure 14. Global Loxoprofen API (Sodium Salt) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Loxoprofen API (Sodium Salt) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Loxoprofen API (Sodium Salt) Sales Value Share by Type (2021-2032) Figure 17. Oral Dosage Image Figure 18. External Preparation Image Figure 19. Global Loxoprofen API (Sodium Salt) Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 20. Global Loxoprofen API (Sodium Salt) Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Loxoprofen API (Sodium Salt) Sales Volume Share by Application (2021-2032) Figure 22. Global Loxoprofen API (Sodium Salt) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Loxoprofen API (Sodium Salt) Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Loxoprofen API (Sodium Salt) Sales Value Share by Application (2021-2032) Figure 25. Global Loxoprofen API (Sodium Salt) Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Loxoprofen API (Sodium Salt) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Loxoprofen API (Sodium Salt) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Loxoprofen API (Sodium Salt) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 30. North America Loxoprofen API (Sodium Salt) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Loxoprofen API (Sodium Salt) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Loxoprofen API (Sodium Salt) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 36. South America Loxoprofen API (Sodium Salt) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Loxoprofen API (Sodium Salt) Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Loxoprofen API (Sodium Salt) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Loxoprofen API (Sodium Salt) Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Loxoprofen API (Sodium Salt) Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥99%
  • Purity<99%
Applications
  • Oral Dosage
  • External Preparation
Companies covered
  • Anlon Healthcare
  • Daiichi Sankyo
  • Metrochem
  • Shinpoong Pharm
  • Dongyue Pharma
  • Hunan Jiudian Hongyang
  • Luoxin Pharmaceutical
  • Apeloa Pharmaceutical
  • Zhejiang Starry Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  4. 1.2.2 Global Loxoprofen API (Sodium Salt) Sales Volume (2021-2032)
  5. 1.2.3 Global Loxoprofen API (Sodium Salt) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Loxoprofen API (Sodium Salt) Market Dynamics
  1. 2.1 Loxoprofen API (Sodium Salt) Industry Trends
  2. 2.2 Loxoprofen API (Sodium Salt) Industry Drivers
  3. 2.3 Loxoprofen API (Sodium Salt) Industry Opportunities and Challenges
  4. 2.4 Loxoprofen API (Sodium Salt) Industry Restraints
3 Loxoprofen API (Sodium Salt) Market by Company
  1. 3.1 Global Loxoprofen API (Sodium Salt) Company Revenue Ranking in 2025
  2. 3.2 Global Loxoprofen API (Sodium Salt) Revenue by Company (2021-2026)
  3. 3.3 Global Loxoprofen API (Sodium Salt) Sales Volume by Company (2021-2026)
  4. 3.4 Global Loxoprofen API (Sodium Salt) Average Price by Company (2021-2026)
  5. 3.5 Global Loxoprofen API (Sodium Salt) Company Ranking (2024-2026)
  6. 3.6 Global Loxoprofen API (Sodium Salt) Company Manufacturing Base and Headquarters
  7. 3.7 Global Loxoprofen API (Sodium Salt) Company Product Type and Application
  8. 3.8 Global Loxoprofen API (Sodium Salt) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Loxoprofen API (Sodium Salt) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Loxoprofen API (Sodium Salt) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Loxoprofen API (Sodium Salt) Market by Type
  1. 4.1 Loxoprofen API (Sodium Salt) Type Introduction
  2. 4.1.1 Purity ≥99%
  3. 4.1.2 Purity<99%
  4. 4.2 Global Loxoprofen API (Sodium Salt) Sales Volume by Type
  5. 4.2.1 Global Loxoprofen API (Sodium Salt) Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Loxoprofen API (Sodium Salt) Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Loxoprofen API (Sodium Salt) Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Loxoprofen API (Sodium Salt) Sales Value by Type
  9. 4.3.1 Global Loxoprofen API (Sodium Salt) Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Loxoprofen API (Sodium Salt) Sales Value by Type (2021-2032)
  11. 4.3.3 Global Loxoprofen API (Sodium Salt) Sales Value Share by Type (2021-2032)
5 Loxoprofen API (Sodium Salt) Market by Application
  1. 5.1 Loxoprofen API (Sodium Salt) Application Introduction
  2. 5.1.1 Oral Dosage
  3. 5.1.2 External Preparation
  4. 5.2 Global Loxoprofen API (Sodium Salt) Sales Volume by Application
  5. 5.2.1 Global Loxoprofen API (Sodium Salt) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Loxoprofen API (Sodium Salt) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Loxoprofen API (Sodium Salt) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Loxoprofen API (Sodium Salt) Sales Value by Application
  9. 5.3.1 Global Loxoprofen API (Sodium Salt) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Loxoprofen API (Sodium Salt) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Loxoprofen API (Sodium Salt) Sales Value Share by Application (2021-2032)
6 Loxoprofen API (Sodium Salt) Regional Sales and Value Analysis
  1. 6.1 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Loxoprofen API (Sodium Salt) Sales by Region (2021-2032)
  3. 6.2.1 Global Loxoprofen API (Sodium Salt) Sales by Region: 2021-2026
  4. 6.2.2 Global Loxoprofen API (Sodium Salt) Sales by Region (2027-2032)
  5. 6.3 Global Loxoprofen API (Sodium Salt) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Loxoprofen API (Sodium Salt) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Loxoprofen API (Sodium Salt) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Loxoprofen API (Sodium Salt) Sales Value by Region (2027-2032)
  9. 6.5 Global Loxoprofen API (Sodium Salt) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  12. 6.6.2 North America Loxoprofen API (Sodium Salt) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  15. 6.7.2 Europe Loxoprofen API (Sodium Salt) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Loxoprofen API (Sodium Salt) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  21. 6.9.2 South America Loxoprofen API (Sodium Salt) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Loxoprofen API (Sodium Salt) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Loxoprofen API (Sodium Salt) Sales Value Share by Country, 2025 VS 2032
7 Loxoprofen API (Sodium Salt) Country-level Sales and Value Analysis
  1. 7.1 Global Loxoprofen API (Sodium Salt) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Loxoprofen API (Sodium Salt) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Loxoprofen API (Sodium Salt) Sales by Country (2021-2032)
  4. 7.3.1 Global Loxoprofen API (Sodium Salt) Sales by Country (2021-2026)
  5. 7.3.2 Global Loxoprofen API (Sodium Salt) Sales by Country (2027-2032)
  6. 7.4 Global Loxoprofen API (Sodium Salt) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Loxoprofen API (Sodium Salt) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Loxoprofen API (Sodium Salt) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Loxoprofen API (Sodium Salt) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Loxoprofen API (Sodium Salt) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Loxoprofen API (Sodium Salt) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Anlon Healthcare
  2. 8.1.1 Anlon Healthcare Company Information
  3. 8.1.2 Anlon Healthcare Business Overview
  4. 8.1.3 Anlon Healthcare Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Anlon Healthcare Loxoprofen API (Sodium Salt) Product Portfolio
  6. 8.1.5 Anlon Healthcare Recent Developments
  7. 8.2 Daiichi Sankyo
  8. 8.2.1 Daiichi Sankyo Company Information
  9. 8.2.2 Daiichi Sankyo Business Overview
  10. 8.2.3 Daiichi Sankyo Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Daiichi Sankyo Loxoprofen API (Sodium Salt) Product Portfolio
  12. 8.2.5 Daiichi Sankyo Recent Developments
  13. 8.3 Metrochem
  14. 8.3.1 Metrochem Company Information
  15. 8.3.2 Metrochem Business Overview
  16. 8.3.3 Metrochem Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Metrochem Loxoprofen API (Sodium Salt) Product Portfolio
  18. 8.3.5 Metrochem Recent Developments
  19. 8.4 Shinpoong Pharm
  20. 8.4.1 Shinpoong Pharm Company Information
  21. 8.4.2 Shinpoong Pharm Business Overview
  22. 8.4.3 Shinpoong Pharm Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shinpoong Pharm Loxoprofen API (Sodium Salt) Product Portfolio
  24. 8.4.5 Shinpoong Pharm Recent Developments
  25. 8.5 Dongyue Pharma
  26. 8.5.1 Dongyue Pharma Company Information
  27. 8.5.2 Dongyue Pharma Business Overview
  28. 8.5.3 Dongyue Pharma Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dongyue Pharma Loxoprofen API (Sodium Salt) Product Portfolio
  30. 8.5.5 Dongyue Pharma Recent Developments
  31. 8.6 Hunan Jiudian Hongyang
  32. 8.6.1 Hunan Jiudian Hongyang Company Information
  33. 8.6.2 Hunan Jiudian Hongyang Business Overview
  34. 8.6.3 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hunan Jiudian Hongyang Loxoprofen API (Sodium Salt) Product Portfolio
  36. 8.6.5 Hunan Jiudian Hongyang Recent Developments
  37. 8.7 Luoxin Pharmaceutical
  38. 8.7.1 Luoxin Pharmaceutical Company Information
  39. 8.7.2 Luoxin Pharmaceutical Business Overview
  40. 8.7.3 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Luoxin Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
  42. 8.7.5 Luoxin Pharmaceutical Recent Developments
  43. 8.8 Apeloa Pharmaceutical
  44. 8.8.1 Apeloa Pharmaceutical Company Information
  45. 8.8.2 Apeloa Pharmaceutical Business Overview
  46. 8.8.3 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Apeloa Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
  48. 8.8.5 Apeloa Pharmaceutical Recent Developments
  49. 8.9 Zhejiang Starry Pharmaceutical
  50. 8.9.1 Zhejiang Starry Pharmaceutical Company Information
  51. 8.9.2 Zhejiang Starry Pharmaceutical Business Overview
  52. 8.9.3 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zhejiang Starry Pharmaceutical Loxoprofen API (Sodium Salt) Product Portfolio
  54. 8.9.5 Zhejiang Starry Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Loxoprofen API (Sodium Salt) Value Chain Analysis
  2. 9.1.1 Loxoprofen API (Sodium Salt) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Loxoprofen API (Sodium Salt) Sales Mode & Process
  6. 9.2 Loxoprofen API (Sodium Salt) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Loxoprofen API (Sodium Salt) Distributors
  9. 9.2.3 Loxoprofen API (Sodium Salt) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst